Ally Bridge Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Ally Bridge Group’s Portfolio HARP Stock Details HARP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-428,400	Closed	-$4.87M	–	34
2023 Q4	$4.87M	Buy	+428,400	New	+$3.37M	2.9%	16

Ally Bridge Group's HARP Position: Q1 2024 in Review

Ally Bridge Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q1 2024, closing a stake of 428,400 shares — an estimated $4.87M sold.

Ally Bridge Group first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $4.87M in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

Ally Bridge Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Ally Bridge Group sold 428,400 Harpoon Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.87M.
Ally Bridge Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2023 and held it in 1 quarter.
Ally Bridge Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $4.87M in Q4 2023.
0 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Ally Bridge Group's 13F filing for Q1 2024, filed 15 May 2024.